Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer 2024-01-29 21:00
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders 2024-01-29 21:00
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial 2024-01-29 21:00
deCODE genetics: A sequence variant that increases risk of pregnancy loss 2024-01-29 18:00
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU 2024-01-29 16:17
Asieris Presents for the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU 2024-01-29 14:05
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide 2024-01-26 20:08
FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System 2024-01-26 15:26
AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site 2024-01-26 08:30
Ceva Santé Animale acquires Scout Bio, paving the way for groundbreaking innovations in pet therapeutics 2024-01-26 06:00
First International Shipment of HANSIZHUANG Launched 2024-01-25 21:41
Esaote unveils its new brand identity at 2024 Worldwide Sales & Marketing Meeting, Florence 2024-01-25 21:00
First International Shipment of HANSIZHUANG 2024-01-25 20:45
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:38
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World 2024-01-25 18:00
Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU 2024-01-25 16:56
Alphamab Oncology and 3DMedicines Entered into a Licensing Agreement with Glenmark for KN035 2024-01-25 10:40
PS128 Successfully Targets Behavioral and Emotional Challenges in Autism Spectrum Disorder (ASD): Completion of Pivotal Clinical Trial on Preschool Children with ASD 2024-01-25 10:00
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect 2024-01-25 08:30
icotec ag raises $30m in growth financing from MVM Partners 2024-01-25 01:45
1 100 101 102 103 104 963